
Laparoscopic cholecystectomy (LC) was first performed by Philippe in France in 1987, and has become the standard treatment method for benign gallbladder (GB) disease, such as symptomatic GB stones and GB polyps [1]. Conventional LC (CLC) is typically performed through four ports, but continuous advancements have been made to reduce access injuries, improving cosmetic outcomes and postoperative recovery. Single-incision LC (SILC) is part of this effort. SILC has been shown in the literature to have several advantages over CLC [2-4]. However, due to the technical difficulties of SILC, several methods have been developed to overcome them [5-7], single-fulcrum LC (SFLC) being one of them. Previous studies have found that SFLC has shown better results for postoperative pain compared to CLC, with no difference in surgical outcome [8,9]. Nevertheless, SFLC has shown several drawbacks.
In recent years, robotic surgical systems for single-port laparoscopic surgery (e.g., Da Vinci SP) have been introduced to overcome the limitations of CLC and SILC, and have been widely adopted [10,11]. Although robotic surgery has many advantages, it also has limitations in terms of cost [12]. The ArtiSential® (LIVSMED Inc.) is a new multi-degree-of-freedom (DOF) articulated laparoscopic instrument that reflects the ergonomics of robotic surgery [13]. This instrument can overcome the spatial limitations of laparoscopic surgery, especially those with fewer ports, such as single-port laparoscopy. In addition to LC, ArtiSential® has been used in various procedures, including appendectomy, gastrectomy, and colon surgery [14-17]. ArtiSential® LC (ALC) is a procedure that has recently been performed extensively in our center, and has evolved through trial and error into a single port +1 format. Moreover, no studies have reported LC using ArtiSential®.
The present study aimed to introduce the ALC technique as practiced in our center, and to compare the surgical outcomes of ALC and SFLC.
This retrospective cohort study compared two groups of patients who underwent ALC and SFLC for uncomplicated GB stones at Severance hospital, with the ALC group that included patients who underwent surgery between 2022 and 2023, and the SFLC group that included patients who underwent surgery between 2009 and 2011. Patients with suspected or definite GB malignancy, GB empyema, or severe acute cholecystitis were excluded. Patient demographics of age, sex, body mass index (BMI), obesity (BMI > 25 kg/m2), American Society of Anesthesiologists (ASA) score, and preoperative symptom status, were collected. Perioperative outcomes were estimated blood loss (EBL), operative time, intraoperative GB rupture, drainage tube insertion, hospital stay, and pain score immediately after surgery, and before discharge. Pain score was expressed on a visual analog scale (VAS) of 0 to 10. This study was approved by the Institutional Review Board of Severance hospital (IRB No. 4−2023−1313) and the requirement for written informed consent was waived due to its retrospective nature.
SFLC is performed by making a transumbilical incision of about 2.0–2.5 cm with a multi-port technique in a single incision, exposing the fascia widely, and inserting into the fascia one of each of a 10, 5, and 2-mm trocar. The fascia is used as a platform. The operator stands on the left side of the patient, while the scopist stands on the right side of the patient. For traction in the cephalad direction of the GB, a 2−0 nylon suture is used to penetrate the top of the GB plate, and pull it out of the abdominal wall, to provide traction and facilitate surgery. Using the 2-mm grasper, the infundibulum is tracted medially with the operator’s right hand, and the Calot’s triangle is dissected with a 5-mm hook to perform surgery (Fig. 1) [8,9,18,19].
The ArtiSential® instruments used are monopolar hook, bipolar fenestrated forceps, and clip applier. Scissors, grasper, dissector, and suction use conventional laparoscopic instruments. The operating room layout is the same as that for the CLC. The surgeon stands on the left side of the patient, while the scopist stands on the left side of the surgeon (Fig. 2). A vertical transumbilical skin incision of approximately 2.0−2.5 cm is made, and a Korean glove port with four passages (Jirehlapa Korea) is inserted. After creating pneumoperitoneum, a camera is inserted to check the abdominal cavity, and an 8-mm trocar is inserted into the patient’s left upper abdomen where the mid-clavicular line and the subcostal area meet. If it is determined that the inflammation or adhesions around the GB in the abdominal cavity are too severe to perform a single-port LC using ArtiSential®, the operation is converted to CLC without delay.
The placement of the glove port is important to prevent collision between the camera and surgical instruments, and to ensure a smooth operation. The laparoscopic camera is inserted through the 9 o’clock opening of the glove port, while the 5-mm grasper is inserted through the 6 o’clock opening of the glove port to help the assistant retract the GB upwards. At this time, the camera can be used more comfortably by using a bent connector that changes the direction of the light source of the laparoscopic camera. Finally, the ArtiSential® fenestrated bipolar forceps are inserted through the 3 o’clock opening of the glove port to complete the placement (Fig. 3). The 8-mm trocar is usually used with an ArtiSential® monopolar hook inserted and a conventional dissector, scissor, and suction, if necessary. The GB is retracted superiorly with a 5-mm grasper held by the assistant, and the Hartmann’s pouch is retracted with bipolar fenestrated forceps to expose the Calot triangle. Using the appropriate articulation of the ArtiSential®, Calot’s triangle is dissected, the cystic duct and cystic artery are isolated, and they are ligated using the ArtiSential® clip applicator. When detaching the GB from the liver, the medial to lateral direction can be used to detach the GB without instrument collision. Bipolar fenestrated forceps are used to control bleeding (Fig. 4). The specimen is removed through the umbilical incision using an endopouch, and the wound is closed [20]. Supplementary Video 1 shows a detailed surgical procedure for ALC.
Categorical variables were presented as frequencies in percentages, and continuous variables were expressed as means and standard deviations. Statistical significance between groups was assessed using the chi-squared test for categorical variables, and the student’s t-test for continuous variables. For all tests, a p-value < 0.05 was considered significant. All analyses were performed with IBM SPSS v26.0 (IBM Corp.). Furthermore, to reduce selection bias between the ALC group and SFLC group, we performed propensity score matching (PSM) using the MatchIt package in R statistical software version 4.4.1 to hypothesize that the ALC group had better postoperative outcomes. The propensity score was calculated from a logistic regression model that included age (years), sex, BMI, obesity, ASA score, and preoperative symptoms. After estimating propensity scores, we matched 22 pairs of patients in each of the ALC and SFLC groups using a 1 : 1 nearest neighbor matching algorithm. The standardized mean difference of each covariate was calculated, and to ensure adequate PSM, set to less than 0.1.
A total of 151 patients were included in the study, with 88 in the ALC group, and 63 in the SFLC group. Comparing the characteristics of the two groups, age, BMI, and preoperative symptoms were not different between the two groups, but the sex ratio was more even in the ALC group (male : female = 50% : 50% vs. 76.2% : 13.8%, p = 0.001), and the ASA score was higher in the ALC group (p <0.001). Age also tended to be higher in the ALC group, although the difference was not significant (51.74 vs. 47.92 years, p = 0.072) (Table 1).
Table 1 . Comparison of patient characteristics between ArtiSential® LC and single-fulcrum LC
ArtiSential® LC (n = 88) | Single-fulcrum LC (n = 63) | p-value | |
---|---|---|---|
Age (yr) | 51.74 (13.00) | 47.92 (12.42) | 0.072 |
Male/female | 44/44 (50.0/50.0) | 48/15 (76.2/13.8) | 0.001 |
BMI (kg/m2) | 24.04 (3.36) | 24.22 (2.97) | 0.735 |
Obesity (BMI > 25 kg/m2) | 31 (35.2) | 25 (39.7) | 0.287 |
ASA score | < 0.001 | ||
Class I | 14 (15.9) | 55 (87.3) | |
Class II | 65 (73.9) | 8 (12.7) | |
Class III | 9 (10.2) | 0 (0.0) | |
Preoperative symptom (yes/no) | 62/26 (70.5/29.5) | 43/20 (68.3/31.7) | 0.569 |
Values are presented as mean (standard deviation) or number (%).
LC, laparoscopic cholecystectomy; BMI, body mass index; ASA, American Society of Anesthesiologists.
Operative and postoperative outcomes showed no difference between the two groups in terms of operative time, EBL, drain insertion, and length of stay, but the ALC group had lower outcomes in terms of operative time > 60 minutes (34.0% vs. 55.6%, p = 0.009) and frequency of intraoperative GB rupture (2.3% vs. 15.9%, p = 0.007). In particular, the postoperative pain scores were lower in the ALC group both immediately after surgery (2.59 vs. 3.73, p < 0.001), and before discharge (1.44 vs. 2.02, p = 0.001) (Table 2). When comparing the two groups after PSM, the frequency of operative time > 60 minutes did not differ between the two groups (p = 0.118), but intraoperative GB rupture was still lower in the ALC group (0% vs. 18.2%, p = 0.021), and postoperative pain scores were lower in the ALC group both immediately after surgery (2.45 vs. 3.64, p = 0.011), and before discharge (1.18 vs. 1.94, p < 0.001) (Table 3, 4).
Table 2 . Comparison of operative and postoperative outcomes between ArtiSential® LC and single-fulcrum LC
ArtiSential® LC (n = 88) | Single-fulcrum LC (n = 63) | p-value | |
---|---|---|---|
Estimated blood loss (mL) | 7.80 (32.69) | 1.43 (7.51) | 0.080 |
Operation time (min) | 57.86 (20.06) | 60.38 (14.37) | 0.396 |
Operation time > 60 min | 30 (34.0) | 35 (55.6) | 0.009 |
GB rupture | 2 (2.3) | 10 (15.9) | 0.007 |
Drainage tube insertion | 1 (1.1) | 0 (0.0) | 0.399 |
Length of stay (day) | 1.47 (0.62) | 1.43 (0.71) | 0.733 |
Pain score (immediate postoperation) | 2.59 (1.70) | 3.73 (2.01) | < 0.001 |
Pain score (at discharge) | 1.44 (1.32) | 2.02 (0.81) | 0.001 |
Values are presented as mean (standard deviation) or number (%).
LC, laparoscopic cholecystectomy; GB, gallbladder.
Table 3 . Comparison of patient characteristics between ArtiSential® LC and single-fulcrum LC after propensity score matching
ArtiSential® LC (n = 22) | Single-fulcrum LC (n = 22) | p-value | |
---|---|---|---|
Age (yr) | 43.95 (14.16) | 50.68 (13.25) | 0.105 |
Male/female | 13/9 (59.1/40.9) | 13/9 (59.1/40.9) | > 0.999 |
BMI (kg/m2) | 24.67 (4.04) | 24.14 (2.85) | 0.616 |
Obesity (BMI > 25 kg/m2) | 9 (40.9) | 8 (36.4) | 0.764 |
ASA score | > 0.999 | ||
Class I | 14 (63.6) | 14 (63.6) | |
Class II | 8 (36.4) | 8 (36.4) | |
Class III | 0 (0.0) | 0 (0.0) | |
Preoperative symptom (yes/no) | 18/4 (81.8/18.2) | 16/6 (72.7/27.3) | 0.483 |
Values are presented as mean (standard deviation) or number (%).
LC, laparoscopic cholecystectomy; BMI, body mass index; ASA, American Society of Anesthesiologists.
Table 4 . Comparison of operative and postoperative outcomes between ArtiSential® LC and single-fulcrum LC after propensity score matching
ArtiSential® LC (n = 22) | Single-fulcrum LC (n = 22) | p-value | |
---|---|---|---|
Estimated blood loss (mL) | 13.59 (45.18) | 1.82 (5.89) | 0.119 |
Operation time (min) | 65.18 (22.52) | 59.00 (13.69) | 0.139 |
Operation time > 60 min | 10 (45.5) | 14 (63.6) | 0.118 |
GB rupture | 0 (0.0) | 4 (18.2) | 0.021 |
Drainage tube insertion | 0 (0.0) | 0 (0.0) | > 0.999 |
Length of stay (day) | 1.64 (0.79) | 1.45 (0.86) | 0.234 |
Pain score (immediate postoperation) | 2.45 (1.50) | 3.64 (1.76) | 0.011 |
Pain score (at discharge) | 1.18 (0.66) | 1.91 (0.68) | < 0.001 |
Values are presented as mean (standard deviation) or number (%).
LC, laparoscopic cholecystectomy; GB, gallbladder.
LC is widely performed as the standard treatment for benign GB disease, and the trend is towards less invasive procedures. As a result, minimally invasive LC procedures have been developed to reduce the number of incisions, and SILC has evolved in this regard, with several methods having been proposed [2-4]. Compared to CLC, SILC uses only one incision, which reduces postoperative pain compared to CLC, which requires multiple incisions; has advantages, such as faster recovery and fewer postoperative complications; and is known to provide patients with relative psychological satisfaction, due to fewer incisions and faster recovery [5-7,21,22]. SFLC, which has been introduced and implemented in our center, is one of these methods, and is a single-incision and multi-port technique that is performed by inserting three trocars into the fascia, with wide exposure of the fascia, after making a transumbilical incision. Compared to SILC, this technique has the advantage of being easier to perform due to less instrument collision; it also has a clear cost advantage [8,9]. However, the disadvantages of SFLC are that the main procedure is handled by the operator’s left hand, which can be a barrier for right-handed operators; and if the patient has an umbilical hernia, the fascia is not intact, which can cause intraoperative air leakage, and make the operation difficult. In addition, the frequency of intraoperative bile leakage was higher than in CLC.
The rise of robotic surgery since the 2000s has led to the introduction of robotic single-site cholecystectomy (RSSC), to overcome the spatial limitations of SILC. In RSSC, the movement of surgical instruments is relocated, allowing the surgeon to control the instruments intuitively and ergonomically through a single surgical site from a surgical console [10,11]. The advantage is that unnecessary movements due to hand tremors or the leverage principle are eliminated, allowing much greater freedom of movement in the abdominal cavity. However, the disadvantage of RSSC is its low cost-effectiveness, compared to other non-robotic LC surgeries [23,24]. Since RSSC has this cost limitation, several devices with articulation have been developed to realize the ergonomic advantages of robotic surgery in the laparoscopic setting [25], and ArtiSential® is one of them. ArtiSential® is a single-use, articulated, multi-DOF surgical instrument, and the world’s only low-cost, hand-held surgical instrument that combines the main advantages of robotics: the articulated structure of the forceps and their intuitive manipulation [13]. Since its introduction in 2019, ArtiSential® has been applied in a variety of surgeries, and is especially effective in surgical methods with space limitations, such as single-port laparoscopic surgery. It can be applied to SILC, a representative single-port laparoscopic surgery, and through several trials and errors, our center has developed and applied an effective ALC method for both surgeons and patients.
In this study, patients who underwent LC for uncomplicated GB stones were studied, and the ALC group had a lower postoperative pain score and a lower frequency of intraoperative bile leakage compared to the SFLC group, while there was no significant difference between the two groups in other surgical outcomes, such as operative time, EBL, and length of stay. As a result, when comparing the two minimally invasive techniques, ALC was found to be a better surgical procedure for patients. The reason for the pain score being significantly lower in ALC compared to SFLC is thought to be due to the number of fascia incisions and more fascia exploration for exposure in SFLC. Also, in SFLC, monopolar cauterization was used diffusely to control the bleeding focus in the liver bed, but in ALC, bipolar fenestrated forceps were used to cauterize only the bleeding focus area, which may have contributed to the difference in pain. In addition, the intuitive control provided by the articulation and ergonomic design of ArtiSential® also benefits the operator, allowing for precise and controlled manipulation during dissection around GB, reducing the likelihood of unnecessary trauma to surrounding tissues, which can help alleviate postoperative pain. Although we used an additional 8-mm trocar in the ALC, the pain scores were low even in this situation, and as 5-mm instruments are expected to be available soon, we expect that with a smaller incision size, the pain will be even lower.
The incidence of intraoperative GB rupture was also lower with ALC. GB rupture during cholecystectomy is associated with increased postoperative pain due to bile spillage and potential peritoneal irritation [26]; therefore, the lower incidence of GB rupture in the ALC group may be associated with lower postoperative pain scores. In addition, previous literature has reported a poor prognosis for intraoperative GB perforation in patients with GB malignancy [27]. This suggests that patients with suspected GB malignancy, such as large polyps, can be safely operated on with ALC. Although this study was conducted in patients with uncomplicated GB stones, the multi-joint, multi-DOF features of the ArtiSential® can be used to safely perform surgery in complicated GB disease. In fact, our center has safely performed with ArtiSential® many cases of partial cholecystectomy for severe cholecystitis.
The disadvantage of ALC is that it is cheaper than RSSC, but more expensive than SFLC. Since SFLC uses most of the equipment of CLC, the cost is almost the same as that for CLC; however, ArtiSential® is relatively expensive, since the price of the instrument is higher than those of laparoscopic instruments. In addition, ArtiSential® has the disadvantage that the learning curve can be long, as surgeons may be confused when they first encounter ALC, since it combines the fulcrum principle of laparoscopic surgery and the intuitive movement of robotic surgery in one instrument. Finally, the large size and weight of the instrument can make it difficult for surgeons with small hands or limited strength to use it effectively. Nevertheless, as mentioned above, while ArtiSential® has many advantages, fully realizing these benefits will require significant effort from surgeons to understand and master its characteristics. With this dedicated effort, we think that the clinical application of ArtiSential® could serve as an alternative to robotic surgery in the future.
There are several limitations to this study that should be considered. One limitation is the different time periods over which data were collected for the ALC and SFLC groups. These temporal differences may have introduced variability in surgical techniques, advances in devices, and postoperative care protocols, which could independently affect outcomes. Another limitation is that the different time periods resulted in a somewhat different group of surgeons who performed the surgeries. However, since this study compares the experience of a single surgeon who developed different surgical approaches, including both early and advanced experience with each approach may reflect a more balanced view of outcomes, minimizing the impact of differences in surgeon proficiency. To further reduce bias and increase the validity of our findings, we used PSM analysis to minimize potential confounders. This approach helps ensure that differences in observed outcomes are more likely attributable to the surgical method itself, rather than differences in patient population, or the period of surgery.
To the best of our knowledge, this is the first study of LC with ArtiSential®, and it confirms that a less invasive and cosmetic LC can be performed safely and efficiently with ArtiSential®.
In conclusions, ALC has been shown to be a safe and effective treatment for benign GB disease. It has also been shown to have significant advantages over SFLC, particularly in terms of postoperative patient pain. By utilizing the features of ArtiSential®, it is expected that the indication for surgery can be expanded to include complicated GB disease, and that it can be safely operated.
Supplementary data related to this article can be found at https://doi.org/10.14701/ahbps.24-137.
ahbps-29-1-48-supple.mp4This research was presented in part as a poster oral presentation at STS 2023 Korea on September 8, 2023, where it was awarded second prize.
This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI22C0767).
No potential conflict of interest relevant to this article was reported.
Conceptualization: CMK, SSH, MC, SYR. Data curation: JHJ, CMK, SSH, MC, SYR. Methodology: All authors. Visualization: All authors. Writing - original draft: JHJ, SSH, MC, SYR. Writing - review & editing: CMK, SSH, MC, SYR. Final approval of manuscript: All authors.
![]() |
![]() |